Your browser doesn't support javascript.
loading
Metastatic Medullary Thyroid Cancer: The Role of 68Gallium-DOTA-Somatostatin Analogue PET/CT and Peptide Receptor Radionuclide Therapy.
Hayes, Aimee R; Crawford, Alexander; Al Riyami, Khulood; Tang, Christine; Bomanji, Jamshed; Baldeweg, Stephanie E; Wild, Damian; Morganstein, Daniel; Harry, Alice; Grozinsky-Glasberg, Simona; Oleinikov, Kira; Khoo, Bernard; Caplin, Martyn E; Nicolas, Guillaume P; Grossman, Ashley B.
Affiliation
  • Hayes AR; Neuroendocrine Tumour Unit, ENETS Centre of Excellence, Royal Free Hospital, London, UK.
  • Crawford A; Medical school, University College of London, London, UK.
  • Al Riyami K; Department of Nuclear Medicine, University College London Hospital, London, UK.
  • Tang C; Department of Radiology, University College London Hospital, London, UK.
  • Bomanji J; Department of Nuclear Medicine, University College London Hospital, London, UK.
  • Baldeweg SE; Department of Radiology, University College London Hospital, London, UK.
  • Wild D; Department of Nuclear Medicine, University College London Hospital, London, UK.
  • Morganstein D; Department of Endocrinology, University College London Hospital, London, UK.
  • Harry A; Division of Medicine, University College London, London, UK.
  • Grozinsky-Glasberg S; Division of Nuclear Medicine, ENETS Centre of Excellence, University Hospital Basel, Basel, Switzerland.
  • Oleinikov K; Thyroid Unit, Royal Marsden Hospital, London, UK.
  • Khoo B; Thyroid Unit, Royal Marsden Hospital, London, UK.
  • Caplin ME; Neuroendocrine Tumour Unit, ENETS Centre of Excellence, Department of Endocrinology and Metabolism, Hadassah Medical Organization and Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
  • Nicolas GP; Neuroendocrine Tumour Unit, ENETS Centre of Excellence, Department of Endocrinology and Metabolism, Hadassah Medical Organization and Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
  • Grossman AB; Neuroendocrine Tumour Unit, ENETS Centre of Excellence, Royal Free Hospital, London, UK.
J Clin Endocrinol Metab ; 106(12): e4903-e4916, 2021 11 19.
Article in En | MEDLINE | ID: mdl-34379772
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Organometallic Compounds / Somatostatin / Thyroid Neoplasms / Receptors, Somatostatin / Receptors, Peptide / Carcinoma, Neuroendocrine / Positron Emission Tomography Computed Tomography Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: J Clin Endocrinol Metab Year: 2021 Type: Article Affiliation country: United kingdom
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Organometallic Compounds / Somatostatin / Thyroid Neoplasms / Receptors, Somatostatin / Receptors, Peptide / Carcinoma, Neuroendocrine / Positron Emission Tomography Computed Tomography Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: J Clin Endocrinol Metab Year: 2021 Type: Article Affiliation country: United kingdom